Figure 2From: Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedropsThe level of ECP in the tears of each eye and the statistical analysis of the change. a. The level of ECP in the tears of each eye at before- and 2 and 4–6 weeks after the start of rebamipide treatment (ECP was not measured in case 1). b. The statistical analysis of the change in the tear level of IL-8 in the four eyes. Pretreatment levels are recorded as 1 on the y axis. The length of treatment is indicated on the x axis. Data are the mean (95% confidence limits) ± SD.Back to article page